Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Kristina Simacek, Christopher Curran, Peter Fenici & Ricardo Garcia-Sanchez. (2019) Patient perceptions of their glycemic control and its influence on type 2 diabetes outcomes: an international survey of online communities. Patient Preference and Adherence 13, pages 295-307.
Read now
Read now
Stewart B Harris, Kamlesh Khunti, Mona Landin-Olsson, Claus B Galbo-Jørgensen, Mette Bøgelund, Barrie Chubb, Jens Gundgaard & Marc Evans. (2013) Descriptions of health states associated with increasing severity and frequency of hypoglycemia: a patient-level perspective. Patient Preference and Adherence 7, pages 925-936.
Read now
Read now
Stephen Brunton, Stephen Gough, Debbie Hicks, Jianping Weng, Etie Moghissi, Mark Peyrot, Doron Schneider, Petra Maria Schumm-Draeger, Christine Tobin & Anthony H. Barnett. (2011) A look into the future: improving diabetes care by 2015. Current Medical Research and Opinion 27:sup3, pages 65-72.
Read now
Read now
Birtha Hansen & Irina Matytsina. (2011) Insulin administration: selecting the appropriate needle and individualizing the injection technique. Expert Opinion on Drug Delivery 8:10, pages 1395-1406.
Read now
Read now
Articles from other publishers (13)
Kui Peng, Gang Chen, Chao Liu, Yiming Mu, Zhen Ye, Lixin Shi, Jiajun Zhao, Lulu Chen, Qiang Li, Tao Yang, Li Yan, Qin Wan, Shengli Wu, Guixia Wang, Zuojie Luo, Xulei Tang, Yanan Huo, Zhengnan Gao, Qing Su, Youmin Wang, Guijun Qin, Huacong Deng, Xuefeng Yu, Feixia Shen, Li Chen, Liebin Zhao, Yu Xu, Min Xu, Yuhong Chen, Jieli Lu, Lin Lin, Rui Du, Meng Dai, Mian Li, Tiange Wang, Zhiyun Zhao, Di Zhang, Yufang Bi, Donghui Li, Weiqing Wang & Guang Ning. (2018) Association between smoking and glycemic control in diabetic patients: Results from the Risk Evaluation of cAncers in Chinese diabeTic Individuals: A lONgitudinal (REACTION) study. Journal of Diabetes 10:5, pages 408-418.
Crossref
Crossref
Alena Welters, Carina Klüppel, Jessica Mrugala, Laura Wörmeyer, Thomas Meissner, Ertan Mayatepek, Christian Heiss, Daniel Eberhard & Eckhard Lammert. (2017) NMDAR antagonists for the treatment of diabetes mellitus-Current status and future directions. Diabetes, Obesity and Metabolism 19, pages 95-106.
Crossref
Crossref
H Brath, P M Paldánius, G Bader, W M Kolaczynski & P M Nilsson. (2016) Differences in glycemic control across world regions: a post-hoc analysis in patients with type 2 diabetes mellitus on dual antidiabetes drug therapy. Nutrition & Diabetes 6:7, pages e217-e217.
Crossref
Crossref
Kamlesh Khunti, Xavier Cos & Guy Rutten. (2014) Insulin degludec – The impact of a new basal insulin on care in type 2 diabetes. Primary Care Diabetes 8:2, pages 119-125.
Crossref
Crossref
Yukiko Onishi, Yasuhiko Iwamoto, Soon Jib Yoo, Per Clauson, Søren C Tamer & Sungwoo Park. (2013)
Insulin degludec compared with insulin glargine in insulin‐naïve patients with type 2 diabetes:
A
26‐week, randomized, controlled,
P
an‐
A
sian, treat‐to‐target trial
. Journal of Diabetes Investigation 4:6, pages 605-612.
Crossref
Crossref
Siddharth ShahWenying YangMohammad Imtiaz HasanRachid MalekOle Molskov BechPhilip Home. (2013)
Biphasic Insulin Aspart 30 in Insulin-Naive People with Type 2 Diabetes in Non-western Nations: Results from a Regional Comparative Multinational Observational Study (A
1
chieve)
. Diabetes Technology & Therapeutics 15:11, pages 954-963.
Crossref
Crossref
Allan Vaag & Sørens Lund. (2012) THERAPY OF ENDOCRINE DISEASE: Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues. European Journal of Endocrinology 166:2, pages 159-170.
Crossref
Crossref
Hamida Khan, Shawarna S. Lasker & Tahseen A. Chowdhury. (2011) Exploring reasons for very poor glycaemic control in patients with Type 2 diabetes. Primary Care Diabetes 5:4, pages 251-255.
Crossref
Crossref
Tim Heise, Cees J. Tack, Robert Cuddihy, Jaime Davidson, Didier Gouet, Andreas Liebl, Enrique Romero, Henriette Mersebach, Patrik Dykiel & Rolf Jorde. (2011) A New-Generation Ultra-Long-Acting Basal Insulin With a Bolus Boost Compared With Insulin Glargine in Insulin-Naïve People With Type 2 Diabetes. Diabetes Care 34:3, pages 669-674.
Crossref
Crossref
Bernard Zinman, Greg Fulcher, Paturi V Rao, Nihal Thomas, Lars A Endahl, Thue Johansen, Rebecka Lindh, Andrew Lewin, Julio Rosenstock, Michel Pinget & Chantal Mathieu. (2011) Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial. The Lancet 377:9769, pages 924-931.
Crossref
Crossref
Bernard Zinman. (2011) Initial Combination Therapy for Type 2 Diabetes Mellitus: Is It Ready for Prime Time?. The American Journal of Medicine 124:1, pages S19-S34.
Crossref
Crossref
Francisco J. A. de Paula, Mark C. Horowitz & Clifford J. Rosen. (2010) Novel insights into the relationship between diabetes and osteoporosis. Diabetes/Metabolism Research and Reviews 26:8, pages 622-630.
Crossref
Crossref
Kristin Plack, Stephan Herpertz & Frank Petrak. (2010) Behavioral medicine interventions in diabetes. Current Opinion in Psychiatry 23:2, pages 131-138.
Crossref
Crossref